Saitech Pharmaceuticals

Saitech Therapeutics is a biotechnology company focused on the discovery and development of a novel class of medicines that target RNA with small molecules. The company utilizes its proprietary RNA-Targeting Small Molecule (rTSM) platform to identify and bind small molecules to specific RNA structures, enabling the modulation of proteins previously considered undruggable. By targeting the RNA itself rather than the resulting protein, Saitech aims to expand the therapeutic landscape for complex diseases. Their current research efforts are primarily concentrated on high-unmet-need areas within oncology and immunology. Headquartered in Princeton, New Jersey, the company is led by experienced drug discovery professionals with a track record in major pharmaceutical organizations.